The first patient has been implanted in a Defense Department-funded clinical trial evaluating Neuronoff’s Injectrode device for the treatment of neurogenic bladder in people with spinal cord injury.
Neuronoff, Inc., a clinical-stage neuromodulation company, today announced the first patient implant in a Department of ...
Pulsetto and Truvaga are closer to clinical neurostimulation devices, while Apollo is described as a sensory-based wearable ...
Vagus nerve stimulation devices are becoming more popular to help people deal with stress, anxiety and sleep issues.
Introduction Misophonia is a newly recognised sound sensitivity disorder with clinically significant symptoms affecting up to 18% of the population. It is characterised by extreme negative reactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results